Australian Clinical Labs (ASX:ACL) Long-Term Capital Lease Obligation : A$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Long-Term Capital Lease Obligation?

Australian Clinical Labs's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.0 Mil.

Australian Clinical Labs's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (A$0.0 Mil) to Jun. 2023 (A$149.5 Mil) but then declined from Jun. 2023 (A$149.5 Mil) to Dec. 2023 (A$0.0 Mil).

Australian Clinical Labs's annual Long-Term Capital Lease Obligation increased from Jun. 2021 (A$124.5 Mil) to Jun. 2022 (A$167.6 Mil) but then declined from Jun. 2022 (A$167.6 Mil) to Jun. 2023 (A$149.5 Mil).

Australian Clinical Labs Long-Term Capital Lease Obligation Historical Data

The historical data trend for Australian Clinical Labs's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Long-Term Capital Lease Obligation Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Long-Term Capital Lease Obligation

95.60

124.54

167.61

149.54

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	167.61	-	149.54	-

Australian Clinical Labs (ASX:ACL) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Australian Clinical Labs Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines